Vitamin B5 could be the key to treating a rare genetic disease, a study has found.

Published Date: 08 Mar 2023

A study by Concordia undergraduate students suggests that a simple vitamin can cure a rare but life-threatening disease.

Read Full News

Latest News

Lancet Medical Journal Declined US Senate COVID Origins Ask

Leading medical journal The Lancet will decline a request to provide evidence for a ⁠U.S. Senate inquiry into the origins of the COVID-19 pandemic, its editor-in-chief...

Ghana Rejects Proposed US Health Aid Deal, Citing Data Concerns, Source Says

Ghana has rejected a bilateral health deal with the U.S., a source familiar with the negotiations told Reuters, the latest stumbling ⁠block to the Trump administration's...

WHO Global Alliance Delivers 100 M Child Vaccines Since 2023

More than 100 million vaccine doses have been delivered to millions of children since ⁠2023 under a global drive to reverse pandemic-related declines in childhood immunisation.

US Military No Longer Required to Get Flu Vaccine, Hegseth Says

The Pentagon will no longer require members of the U.S. military to get the ⁠flu vaccine, Defense Secretary Pete Hegseth said on Tuesday.

Moderna Starts Late-stage Trial of Bird Flu Vaccine in US, UK

Moderna said on Tuesday it had started a late-stage study of its experimental bird flu vaccine ⁠in the U.S. and the UK, marking the first time a pandemic bird flu vaccine...

The Long-COVID Crisis: No Cure, Little Attention

On International Long COVID Awareness Day, advocates warned that long COVID — affecting 400 million people — remains underrecognized by clinicians and underfunded.

Todays Updates

AstraZeneca to Invest $405 Million in Britain After US-UK Pharma Deal

Prime Minister Keir Starmer said on Wednesday that Britain's biggest company AstraZeneca would invest 300 million pounds ($405 ⁠million) in the country, after pausing...

Upadacitinib After TNF Inhibitor Failure Improves RA Control

In patients with active RA, switching to upadacitinib after failure of a single TNF inhibitor is more effective in reducing disease activity at 12 weeks than using a second TNF inhibitor adalimumab.

AAN 2026: Key RRMS Clinical Trial Updates

Dr Chu-Yueh Guo discusses promising MS trial results, including a study of fenebrutinib and positive safety data for ocrelizumab in pregnancy and pediatric patients.

Are Smartwatches Changing Arrhythmia Care?

Wearables can flag AF and capture symptoms in real time — but who truly benefits? Cardiologist Walid Amara, MD, outlines where smartwatches fit in clinical practice.

Why the FDA Rejected RP-1 in Melanoma: A Data Deep Dive

Dr Bishal Gyawali unpacks the FDA’s decision to deny RP-1 in melanoma, exploring why single-arm data and confounded response rates failed to meet the bar for clinical evidence.

Differential Diagnosis of Suspected Pulmonary Fibrosis and Efficacy of Approved Therapies

Experts review the differential diagnosis of suspected IPF, highlighting how a multidisciplinary approach confirmed the diagnosis and informed selection of optimal antifibrotic therapy.

‘Living’ Database Tracks Psilocybin Trials for Depression

Sypres.io continuously tracks and evaluates psychedelic research, offering an up-to date view of study findings, design, and limitations.

Todays Updates

AstraZeneca to Invest $405 Million in Britain After US-UK Pharma Deal

Prime Minister Keir Starmer said on Wednesday that Britain's biggest company AstraZeneca would invest 300 million pounds ($405 ⁠million) in the country, after pausing...

Upadacitinib After TNF Inhibitor Failure Improves RA Control

In patients with active RA, switching to upadacitinib after failure of a single TNF inhibitor is more effective in reducing disease activity at 12 weeks than using a second TNF inhibitor adalimumab.

AAN 2026: Key RRMS Clinical Trial Updates

Dr Chu-Yueh Guo discusses promising MS trial results, including a study of fenebrutinib and positive safety data for ocrelizumab in pregnancy and pediatric patients.

Are Smartwatches Changing Arrhythmia Care?

Wearables can flag AF and capture symptoms in real time — but who truly benefits? Cardiologist Walid Amara, MD, outlines where smartwatches fit in clinical practice.

Why the FDA Rejected RP-1 in Melanoma: A Data Deep Dive

Dr Bishal Gyawali unpacks the FDA’s decision to deny RP-1 in melanoma, exploring why single-arm data and confounded response rates failed to meet the bar for clinical evidence.

Differential Diagnosis of Suspected Pulmonary Fibrosis and Efficacy of Approved Therapies

Experts review the differential diagnosis of suspected IPF, highlighting how a multidisciplinary approach confirmed the diagnosis and informed selection of optimal antifibrotic therapy.

‘Living’ Database Tracks Psilocybin Trials for Depression

Sypres.io continuously tracks and evaluates psychedelic research, offering an up-to date view of study findings, design, and limitations.

Latest News

Leading medical journal The Lancet will decline a request to provide evidence for a ⁠U.S. Senate inquiry into the origins of the COVID-19 pandemic, its editor-in-chief...

Ghana has rejected a bilateral health deal with the U.S., a source familiar with the negotiations told Reuters, the latest stumbling ⁠block to the Trump administration's...

More than 100 million vaccine doses have been delivered to millions of children since ⁠2023 under a global drive to reverse pandemic-related declines in childhood immunisation.

The Pentagon will no longer require members of the U.S. military to get the ⁠flu vaccine, Defense Secretary Pete Hegseth said on Tuesday.

Moderna said on Tuesday it had started a late-stage study of its experimental bird flu vaccine ⁠in the U.S. and the UK, marking the first time a pandemic bird flu vaccine...

On International Long COVID Awareness Day, advocates warned that long COVID — affecting 400 million people — remains underrecognized by clinicians and underfunded.

News All Time

Trump Officials Consider Ophthalmologist Hemmati for Top Vaccine Post, Reports Say

The Trump administration is considering appointing Houman Hemmati, an ⁠ophthalmologist and a frequent Fox News guest, to lead the FDA's Center ⁠for Biologics Evaluation and...

Should US Policies Qualify as a Global Health Emergency?

Debate is growing over whether national policy decisions can meet the criteria for global health emergencies, as projections suggest major setbacks in infectious disease control.

US CDC Delays Publishing Report Showing COVID Vaccine Benefits, WaPo Reports

The acting director of ⁠the Centers for Disease Control ⁠and Prevention has delayed publication ⁠of a ‌CDC report showing the COVID-19 vaccine cut the likelihood of...

US FDA Approves Waters' At‑home Cervical Cancer Screening Kit

Lab equipment maker Waters said on Wednesday the U.S. Food and Drug ⁠Administration has cleared its at-home cervical cancer screening kit for use with an ⁠approved HPV test,...

On-Site Hepatitis C Care Boosts Treatment Uptake

On-site hepatitis C virus testing and treatment with peer support at opioid treatment programs boosts access to curative therapy and sharply increases treatment initiation.

Fungal Extract May Improve COVID Vaccine Response

Researchers report that fungal extracts may influence vaccine reactogenicity and antibody kinetics, with effects observed only in individuals without prior SARS-CoV-2 exposure.

Can Severe Infections Raise Your Dementia Risk?

Severe infections such as cystitis and bacterial infection of an unspecified site may raise the risk of developing dementia, even after accounting for other illnesses.

Exclusive-US Upends Global Supply Program for Malaria and HIV Amid Warnings of Gaps

The U.S. is upending the way it delivers medical supplies for diseases such as HIV and malaria to lower-income countries, according to seven sources and an internal email,...

African Ancestry Linked to Fewer TB Adverse Events

A 10% rise in African ancestry lowered odds of moderate TB drug reactions, while a 10% increase in European ancestry raised them — implications for surveillance.

Cervical Cancer Screening Update: Why Less Is More

Cervical cancer screening has evolved. Dr Neil Skolnik delivers an update on why we now wait until age 25 to start and how self-testing is changing the pelvic exam landscape.

Exclusive-Pfizer, BioNTech Halt US COVID Vaccine Study After Recruitment Struggles

Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too...

Low CD4 Count Tied to Cervical Cancer Risk in HIV Infection

A lower CD4 count is associated with a higher risk for cervical carcinoma in situ and cervical cancer in women with HIV infection.

Does HIV Status Affect Long COVID Manifestations?

Patients with HIV infection are at a higher risk of developing long COVID manifestations than those without HIV infection.

Is Integrase Inhibitor-Based HIV Therapy Safe in Pregnancy?

In utero exposure to integrase inhibitor-based antiretroviral regimens is not associated with adverse 1-year neurodevelopmental outcomes compared with exposure to other antiretroviral regimens.

Ryan White: The Safety Net We Cannot Afford to Shrink

Dr Daskalakis shares the important strides that HIV/AIDS care has made and how critical access to care can be for some patients.

Nigerian HIV Volunteers Went Door-to-Door Amid Aid Cuts

For several months last year, Josephine Angev walked the dusty village paths of Nigeria's Benue State to help people living with HIV stay on their life-saving medication.

Recommended News For You

New target points to combination therapy for thwarting multidrug resistance in cancer treatment

PET-CT is better than contrast-enhanced CT as a predictor of survival in patients with metastatic breast cancer

In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.

Congresswoman has cancer; the IRS is suing a controversial doctor; and caffeine and teenagers.

Lung nodules seen in a high percentage of non-smokers

Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD

Breast cancer: A new target to eliminate dormant cells before they wake

Recommended Articles For You

Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options  

ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring 

AI-Powered Case Studies in Oncology: Elevating Clinical Influence Through Real-World Data 

New Frontiers in Diagnosing and Managing Myelodysplastic Syndromes (MASLD) 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Truth About Apple AirPods

2.

New guidelines for radiation therapy for HPV-associated head and neck cancer

3.

Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients

4.

An ultrasound breast patch with conformability might help with early breast cancer detection.

5.

Children living near oil and gas wells face higher risk of rare leukemia, studies show

1.

Tumor Evolution: Signaling, Cancer Cell Plasticity, and Intratumor Heterogeneity

2.

Hematologic Toxicity of CDK4/6 Inhibitors in Breast Cancer: Meta-Analysis and Safety Data

3.

Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era

4.

Exploring the Latest Treatments for Essential Thrombocythemia

5.

Breaking Barriers: Innovative Approaches in Brain Tumor Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII

3.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

5.

Thromboprophylaxis In Medical Settings

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot